Literature DB >> 11050411

Jamming the endosomal system: lipid rafts and lysosomal storage diseases.

K Simons1, J Gruenberg.   

Abstract

Some lysosomal storage diseases result from the accumulation of lipids in degradative compartments of the endocytic pathway. Particularly striking is the example of the Niemann-Pick (NP) syndrome. NP syndromes types A and B are characterized by the accumulation of sphingomyelin, whereas cholesterol typically accumulates in NP type C. These two different lipids, sphingomyelin and cholesterol, are normal constituents of specific lipid microdomains called rafts. Because accumulation of raft lipids is observed not only in NP diseases but also in many other lipidoses, we forward the hypothesis that lysosomal storage diseases can be caused by the accumulation of lipid rafts in late endosomes/lysosomes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050411     DOI: 10.1016/s0962-8924(00)01847-x

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  82 in total

1.  Partitioning of Thy-1, GM1, and cross-linked phospholipid analogs into lipid rafts reconstituted in supported model membrane monolayers.

Authors:  C Dietrich; Z N Volovyk; M Levi; N L Thompson; K Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

Review 2.  Are there useful biochemical markers of disease activity in lysosomal storage diseases?

Authors:  B Winchester
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

3.  Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice.

Authors:  Danielle te Vruchte; Aruna Jeans; Frances M Platt; Daniel John Sillence
Journal:  J Inherit Metab Dis       Date:  2010-05-11       Impact factor: 4.982

Review 4.  The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders.

Authors:  Arash Velayati; W Haung Yu; Ellen Sidransky
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

5.  Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders.

Authors:  Alessandro Fraldi; Fabio Annunziata; Alessia Lombardi; Hermann-Josef Kaiser; Diego Luis Medina; Carmine Spampanato; Anthony Olind Fedele; Roman Polishchuk; Nicolina Cristina Sorrentino; Kai Simons; Andrea Ballabio
Journal:  EMBO J       Date:  2010-09-24       Impact factor: 11.598

6.  Port-to-port delivery: Mobilization of toxic sphingolipids via extracellular vesicles.

Authors:  Giuseppe Scesa; Ana Lis Moyano; Ernesto R Bongarzone; Maria I Givogri
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

7.  δ-Tocopherol Effect on Endocytosis and Its Combination with Enzyme Replacement Therapy for Lysosomal Disorders: A New Type of Drug Interaction?

Authors:  Rachel L Manthe; Jeffrey A Rappaport; Yan Long; Melani Solomon; Vinay Veluvolu; Michael Hildreth; Dencho Gugutkov; Juan Marugan; Wei Zheng; Silvia Muro
Journal:  J Pharmacol Exp Ther       Date:  2019-05-17       Impact factor: 4.030

8.  Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome.

Authors:  Philippe M Campeau; Moutih Rafei; Marie-Noëlle Boivin; Ying Sun; Gregory A Grabowski; Jacques Galipeau
Journal:  Blood       Date:  2009-07-08       Impact factor: 22.113

9.  Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization.

Authors:  Mireille Guyader; Etsuko Kiyokawa; Laurence Abrami; Priscilla Turelli; Didier Trono
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Cyclodextrin triggers MCOLN1-dependent endo-lysosome secretion in Niemann-Pick type C cells.

Authors:  Fabrizio Vacca; Stefania Vossio; Vincent Mercier; Dimitri Moreau; Shem Johnson; Cameron C Scott; Jonathan Paz Montoya; Marc Moniatte; Jean Gruenberg
Journal:  J Lipid Res       Date:  2019-02-01       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.